ClinicalTrials.Veeva

Menu

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

K

Krankenhaus Barmherzige Schwestern Linz

Status

Completed

Conditions

Endometrial Cancer
Atypical Hyperplasia

Treatments

Procedure: hysteroscopy/curettage in case of suspicious aspect will be done a rapid section

Study type

Observational

Funder types

Other

Identifiers

NCT01961102
BHS-Gyn1

Details and patient eligibility

About

It is to be achieved that in postmenopausal women through the combination of Hysteroscopy and intraoperative rapid section a positive predictive value (PPV) regarding the objective illness like endometrial cancer or adenomatous hyperplasia of 100% so as a negative predictive value (NPV) of 99%.

Full description

If a patient fulfills the inclusion criteria, the surgeon decides intraoperatively due to the aspect in the hysteroscopy if it is a clearly benign result or if it looks suspicious or malign.

In case of a hysteroscopical benign result the patient will be informed about the result after the operation.

In case of a hysteroscopal suspicious or malignant aspect, the curettement will be sent for a rapid section. If the hysteroscopic result confirms the hysteroscopic suspicion the patient will be informed after the operation and the further treatment can be planned right away.

Enrollment

300 patients

Sex

Female

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Postmenopausal status (more than 1 year of last menopausal bleeding)
  • Postmenopausal vaginal bleeding
  • Asymptomatic postmenopausal endometrial hyperplasia
  • Understanding of the german language
  • Signature and consent of the patient

Exclusion criteria

  • Not able to understand and participate in the study
  • Premenopausal status
  • no informed consent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems